Correlation study on the establishment of diagnostic criteria for cM0(i+) staging of lung cancer guided by circulating tumor cells (CTC) and its clinical significance

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100052774

Enrollment

Unknown

Registered

2021-11-05

Start date

2021-11-08

Completion date

Unknown

Last updated

2022-08-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-small cell lung cancer (NSCLC)

Interventions

Grouped by different stages:N/A

Eligibility

Sex/Gender

All

Age

18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Newly diagnosed non-small cell lung cancer patients; 2. No antitumor therapy was performed before surgery; 3. Not accompanied by malignant tumors of other organs; 4. Patients undergoing surgical resection; 5. Eastern Cooperative Oncology Group Activity Status Scale (ECOG) performance status of 0 or 1; 6. Aged 18-85 years; 7. No metastasis, predicted disease-free time > 6 months; 8. Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests and other research procedures; 9. Complete medical records.

Exclusion criteria

Exclusion criteria: 1. Patients with severe complications 4 weeks after surgery; 2. Pregnant or breastfeeding; 3. Other serious acute or chronic physical or mental illness; 4. Lost patients.

Design outcomes

Primary

Measure	Time frame
Progression-free survival;	—

Secondary

Measure	Time frame
Overall survival;Circulating tumor cell;	—

Countries

China

Contacts

Public ContactLi Gang

Sichuan Academy of Medical Sciences/Sichuan Provincial People's Hospital

370895713@qq.com+86 13568941464

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026